Extract from the Register of European Patents

EP About this file: EP1790660

EP1790660 - Heterologous expression of neisserial proteins [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.04.2013
Database last updated on 09.04.2026
Most recent event   Tooltip02.11.2018Change - lapse in a contracting statepublished on 05.12.2018  [2018/49]
Applicant(s)For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena (SI) / IT
[2012/25]
Former [2007/22]For all designated states
Novartis Vaccines and Diagnostics S.r.l.
Via Fiorentina 1
53100 Siena SI / IT
Inventor(s)01 / Arico, Maria B.
Novartis Vaccines Diagnostics SRL
Via Fiorentina 1
53100 Siena / IT
02 / Comanducci, Maurizio
Novartis Vaccines Diagnostics SRL
Via Fiorentina 1
53100 Siena / IT
03 / Galeotti, Cesira
Novartis Vaccines Diagnostics SRL
Via Fiorentina 1
53100 Siena / IT
04 / Masignani, Vega
Novartis Vaccines Diagnostics SRL
Via Fiorentina 1
53100 Siena / IT
05 / Guiliani, Marzia Monica
Novartis Vaccines Diagnostics SRL
Via Fiorentina 1
53100 Siena / IT
06 / Pizza, Mariagrazia
Novartis Vaccines Diagnostics SRL
Via Fiorentina 1
53100 Siena / IT
 [2012/25]
Former [2007/22]01 / Arico, Maria B.
Novartis Vaccines Diagnostics SRL, Via Fiorentina 1
53100 Siena / IT
02 / Comanducci, Maurizio
Novartis Vaccines Diagnostics SRL, Via Fiorentina 1
53100 Siena / IT
03 / Galeotti, Cesira
Novartis Vaccines Diagnostics SRL, Via Fiorentina 1
53100 Siena / IT
04 / Masignani, Vega
Novartis Vaccines Diagnostics SRL, Via Fiorentina 1
53100 Siena / IT
05 / Guiliani, Marzia Monica
Novartis Vaccines Diagnostics SRL, Via Fiorentina 1
53100 Siena / IT
06 / Pizza, Mariagrazia
Novartis Vaccines Diagnostics SRL, Via Fiorentina 1
53100 Siena / IT
Representative(s)Marshall, Cameron John, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2012/25]Marshall, Cameron John, et al
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Former [2007/22]Marshall, Cameron John, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date06076718.328.02.2001
[2007/22]
Priority number, dateGB2000000469528.02.2000         Original published format: GB 0004695
GB2000002767513.11.2000         Original published format: GB 0027675
[2007/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1790660
Date:30.05.2007
Language:EN
[2007/22]
Type: A3 Search report 
No.:EP1790660
Date:31.10.2007
[2007/44]
Type: B1 Patent specification 
No.:EP1790660
Date:20.06.2012
Language:EN
[2012/25]
Search report(s)(Supplementary) European search report - dispatched on:EP27.09.2007
ClassificationIPC:C12N15/70, C07K14/22, C07K19/00
[2007/36]
CPC:
C12Q1/689 (EP,US); A61K39/095 (US); A61P31/04 (EP);
A61P37/04 (EP); C07K14/22 (EP,US); C12P21/00 (US);
C12P21/02 (US); A61K2039/545 (US); A61K2039/55505 (US);
A61K2039/572 (US); A61K2039/575 (US); A61K38/00 (EP,US);
C07K2319/00 (EP,US); C12Q2600/156 (EP,US) (-)
Former IPC [2007/22]C07K14/22
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2007/22]
TitleGerman:Heterologe Expression von Neisseria Proteinen[2007/22]
English:Heterologous expression of neisserial proteins[2007/22]
French:Expression hétérologue de protéines de Neisseria[2007/22]
Examination procedure04.04.2008Examination requested  [2008/21]
23.05.2008Despatch of a communication from the examining division (Time limit: M04)
02.10.2008Reply to a communication from the examining division
29.01.2009Despatch of a communication from the examining division (Time limit: M04)
05.06.2009Reply to a communication from the examining division
17.11.2009Despatch of a communication from the examining division (Time limit: M04)
29.03.2010Reply to a communication from the examining division
02.08.2010Despatch of a communication from the examining division (Time limit: M06)
09.02.2011Reply to a communication from the examining division
25.11.2011Date of oral proceedings
19.12.2011Minutes of oral proceedings despatched
28.12.2011Communication of intention to grant the patent
03.05.2012Fee for grant paid
03.05.2012Fee for publishing/printing paid
Parent application(s)   TooltipEP01914109.2  / EP1259627
Divisional application(s)EP10178586.3  / EP2270030
EP10178655.6  / EP2270031
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010914109) is  27.04.2004
Opposition(s)21.03.2013No opposition filed within time limit [2013/22]
Fees paidRenewal fee
13.09.2006Renewal fee patent year 03
13.09.2006Renewal fee patent year 04
13.09.2006Renewal fee patent year 05
13.09.2006Renewal fee patent year 06
13.09.2006Renewal fee patent year 07
13.02.2008Renewal fee patent year 08
13.02.2009Renewal fee patent year 09
16.02.2010Renewal fee patent year 10
15.02.2011Renewal fee patent year 11
15.02.2012Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2016/35]CY20.06.2012
Former [2013/10]CY20.06.2012
Documents cited:Search[XY] FR2720408  (PASTEUR MERIEUX SERUMS VACC et al.)
 [DY] WO9936544  (CHIRON SPA et al.)
 [X] US6013267  (BLAKE MILAN S et al.)
 [X] WO9728273  (NORTH AMERICAN VACCINE INC et al.)
 [X] US6028049  (JACOBS ERIC et al.)
 [X] WO9713860  (PASTEUR MERIEUX SERUMS VACC et al.)
 [X] US5914254  (MASCARENHAS DESMOND et al.)
 [X]   GENEVIVE RENAULD-MONGNIE ET AL.: "Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B", JOURNAL OF BACTERIOLOGY, vol. 179, no. 20, October 1997 (1997-10-01), pages 6400 - 6407, XP002168798
 [X]   LEGRAIN M ET AL: "PRODUCTION OF LIPIDATED MENINGOCOCCAL TRANSFERRIN BINDING PROTEIN 2 IN ESCHERICHIA COLI", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, US, vol. 6, October 1995 (1995-10-01), pages 570 - 578, XP000996792, ISSN: 1046-5928

DOI:   http://dx.doi.org/10.1006/prep.1995.1075
 [X]   BRANDHORST TRISTAN ET AL: "Effects of leader sequences upon the heterologous expression of restrictocin in Aspergillus nidulans and Aspergillus niger", CANADIAN JOURNAL OF MICROBIOLOGY, vol. 41, no. 7, 1995, pages 601 - 611, XP008083802, ISSN: 0008-4166

DOI:   http://dx.doi.org/10.1139/m95-080
ExaminationUS5965424
 WO9957280
by applicantWO9924578
 WO9936544
 WO9957280
 WO0022430
 WO0066791
 WO0066741
 WO0071574
 WO0104316
 WO9955873
   TETTELIN, SCIENCE, vol. 287, 2000, pages 1809 - 1815
   URSINUS; HOLTJE, J. BACT., vol. 176, 1994, pages 338 - 343
   HARZ, ANAL. BIOCHEM., vol. 190, 1990, pages 120 - 128
   GLAUNER, ANAL. BIOCHEM., vol. 172, 1988, pages 451 - 464
   THUNNISSEN, BIOCHEMISTRY, vol. 34, 1995, pages 12729 - 12737
   VAN ASSELT, STRUCTURE FOLD DES, vol. 7, 1999, pages 1167 - 80
   TERRAK, MOL.MICROBIOL., vol. 34, 1999, pages 350 - 64
   VELATI BELLINI, J. BIOTECHNOL., vol. 18, 1991, pages 177 - 192
   ROPP; NICHOLAS, J. BACT., vol. 179, 1997, pages 2783 - 2787
   KRAFT, J. BACT., vol. 180, 1998, pages 3441 - 3447
   THALLER, MICROBIOLOGY, vol. 140, 1994, pages 1341 - 1350
   HOICZYK, EMBO J, vol. 19, 2000, pages 5989 - 99
   EVANS, INFECT.IMMUN., vol. 10, 1974, pages 1010 - 1017
   FILIP, J.BACT., vol. 115, 1973, pages 717 - 722
   DAVIES, J.IMMUNOL.METH., vol. 143, 1990, pages 215 - 225
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.